Internal Medicine, Infectious Disease · Pinehurst, NC
NPI
1174579726
Since 2006
Specialty
Internal Medicine, Infectious Disease
Code 207RI0200X
Group practices
2
Medicare group memberships
Hospitals
3
Hospital affiliations
35 Memorial Dr
Pinehurst, NC, 28374
Phone (910) 715-5481
Groups this clinician bills Medicare through
Medicare paid, 2024
$44K
593 services
Medicare patients, 2024
226
Average age 73
Drug cost, 2024
$1.3M
1,081 prescriptions
Company payments, 2025
$975
From 10 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Jaspaul S Jawanda was code 99232 (hospital e&m - subsequent), 200 times for 99 patients. In total Jaspaul S Jawanda billed 593 services in 16 codes, and Medicare paid $44K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2013-11-06.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99232 Hospital E&M - Subsequent | Facility | 200 | 99 | $57.42 | $11K |
| 99222 Hospital E&M - Initial | Facility | 99 | 92 | $94.38 | $9,344 |
| 99214 Office E&M - Established | Facility | 81 | 55 | $62.01 | $5,022 |
| 99233 Hospital E&M - Subsequent | Facility | 48 | 26 | $87.66 | $4,208 |
| 99223 Hospital E&M - Initial | Facility | 44 | 43 | $115.63 | $5,088 |
| 99213 Office E&M - Established | Facility | 43 | 38 | $46.60 | $2,004 |
| 99215 Office E&M - Established | Facility | 16 | 13 | $101.64 | $1,626 |
| 99204 Office E&M - New | Facility | 15 | 15 | $93.41 | $1,401 |
By year: 2022 $55K for 768 services; 2023 $40K for 533 services; 2024 $44K for 593 services.
Medicare prescription drug claims, 2024
In 2024, the drug Jaspaul S Jawanda prescribed most often to Medicare patients was Biktarvy (Bictegrav/Emtricit/Tenofov Ala), with 119 prescriptions and refills. In total Jaspaul S Jawanda wrote 1,081 Medicare prescriptions that cost $1.3M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Biktarvy Bictegrav/Emtricit/Tenofov Ala | 119 | 119 | 13 | $481K |
| Doxycycline Hyclate Generic | 61 | 71 | 22 | $1,413 |
| Cephalexin Generic | 51 | 85 | 14 | $1,717 |
| Dovato Dolutegravir Sodium/Lamivudine | 47 | 47 | Under 11 | $152K |
| Cefadroxil Generic | 46 | 59 | 15 | $1,605 |
| Amoxicillin-Clavulanate Potass Amoxicillin/Potassium Clav | 45 | 58 | 18 | $1,550 |
| Vancomycin Hcl Generic | 41 | 41 | 11 | $8,494 |
| Daptomycin Generic | 40 | 40 | 12 | $46K |
| Azithromycin Generic | 36 | 45 | 12 | $575 |
| Sulfamethoxazole-Trimethoprim Sulfamethoxazole/Trimethoprim | 32 | 46 | 11 | $270 |
| Clindamycin Hcl Generic | 28 | 30 | Under 11 | $640 |
| Ertapenem Ertapenem Sodium | 26 | 26 | 11 | $11K |
| Ethambutol Hcl Generic | 26 | 44 | Under 11 | $1,184 |
| Tivicay Dolutegravir Sodium | 26 | 26 | Under 11 | $86K |
| Ciprofloxacin Hcl Generic | 24 | 24 | 11 | $176 |
Brand drugs: 327 claims; generic drugs: 754 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Jaspaul S Jawanda $975 ($975 in general payments such as food, travel and fees) from 10 companies. The largest payer was Gilead Sciences, Inc. with $259.
| Company | Payments | Amount |
|---|---|---|
| Gilead Sciences, Inc. GILD | 11 | $259 |
| ViiV Healthcare Company GSK | 9 | $226 |
| Abbvie Inc. ABBV | 5 | $113 |
| Shionogi Inc 4507.T | 5 | $112 |
| Merck Sharp & Dohme LLC MRK | 4 | $77.18 |
| Melinta Therapeutics, LLC | 2 | $49.43 |
| Paratek Pharmaceuticals, Inc. | 2 | $43.43 |
| Pfizer Inc. PFE | 1 | $36.16 |
| Insmed, Inc. INSM | 1 | $29.59 |
| La Jolla Pharmaceutical Company | 1 | $28.2 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.